Berenberg Bank reiterated their buy rating on shares of Bodycote (LON:BOY - Free Report) in a research report released on Friday, Marketbeat reports. Berenberg Bank currently has a GBX 800 ($10.15) price objective on the stock.
Bodycote Trading Down 2.0 %
Shares of LON:BOY traded down GBX 13 ($0.16) during trading on Friday, reaching GBX 649 ($8.23). The company's stock had a trading volume of 230,859 shares, compared to its average volume of 332,062. The stock has a market capitalization of £1.19 billion, a PE ratio of 1,966.67, a price-to-earnings-growth ratio of 1.44 and a beta of 1.18. Bodycote has a 12 month low of GBX 536 ($6.80) and a 12 month high of GBX 774 ($9.82). The company has a current ratio of 0.81, a quick ratio of 0.74 and a debt-to-equity ratio of 20.80. The firm's 50 day simple moving average is GBX 590.73 and its two-hundred day simple moving average is GBX 648.16.
Insider Activity
In related news, insider Daniel A. Dayan purchased 36,000 shares of the business's stock in a transaction dated Friday, October 25th. The shares were purchased at an average cost of GBX 547 ($6.94) per share, for a total transaction of £196,920 ($249,835.07). Insiders own 2.32% of the company's stock.
About Bodycote
(
Get Free Report)
Bodycote plc provides heat treatment and thermal processing services worldwide. It operates in two business areas, Aerospace, Defence & Energy; and Automotive & General Industrial. The company offers heat treatment services, including altering the microstructure of metals and alloys, such as steel and aluminum to impart properties comprising surface hardness, temperature resistance, ductility, and strength; metal joining services consisting of electron beam welding, HIP diffusion bonding, hydrogen brazing, induction brazing, and furnace/vacuum brazing; and hot isostatic pressing (HIP) services, including isostatic pressing and HIP supporting services, as well as Powdermet technology, a manufacturing process used in the production of complex components using powder metallurgy.
Read More
Before you consider Bodycote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bodycote wasn't on the list.
While Bodycote currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.